PMID: 42331726

Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.

Ekinci Elif I, Maldonado Sandra González, Unseld Anna, Martinez Jorge Arrubla, Hennige Anita M, Schoelch Corinna

Diabetes, obesity & metabolism · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.